Anteris Technologies Global Corp (AVR) USD0.0001

Sell:$3.30Buy:$3.63$0.03 (0.72%)

Prices delayed by at least 15 minutes
Sell:$3.30
Buy:$3.63
Change:$0.03 (0.72%)
Prices delayed by at least 15 minutes
Sell:$3.30
Buy:$3.63
Change:$0.03 (0.72%)
Prices delayed by at least 15 minutes

Company Information

About this company

Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Key people

David St Denis
President, Director
Wayne G. Paterson
Chief Executive Officer, Vice Chairman of the Board
Matthew Mcdonnell
Chief Financial Officer
Stephen Denaro
Company Secretary, Non-Executive Director
John Daniel Seaberg
Independent Chairman of the Board
Gregory S. Moss
Director
David Brian Roberts
Director
Click to see more

Key facts

  • EPIC
    AVR
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US03675P1021
  • Market cap
    $137.04m
  • Employees
    136
  • Shares in issue
    36.06m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.